# Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder

> **NCT02517424** · PHASE2 · COMPLETED · sponsor: **Tilray** · enrollment: 6 (actual)

## Conditions studied

- Posttraumatic Stress Disorder

## Interventions

- **DRUG:** High THC/Low CBD Cannabis
- **DRUG:** High THC/High CBD Cannabis
- **DRUG:** Low THC/Low CBD Cannabis

## Key facts

- **NCT ID:** NCT02517424
- **Lead sponsor:** Tilray
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-07
- **Primary completion:** 2019-03-22
- **Final completion:** 2019-03-22
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02517424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02517424, "Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02517424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*